Literature DB >> 24995687

Language in young children with neurofibromatosis-1: relations to functional communication, attention, and social functioning.

Natalie G Brei1, Bonita P Klein-Tasman2, G Nathanael Schwarz3, Christina L Casnar4.   

Abstract

In this study, the language abilities of 30 children with Neurofibromatosis Type 1 (NF1) aged 4-6 years were examined using a standardized measure of language. Relations of language to multiple parental report measures of functional communication, social skills, and attention problems were investigated. Difficulties in core language skills were observed, and more than 1/3 of the children struggled on at least one language index. Language abilities were significantly related to parental report of functional communication, social interaction and communication, and social skills, such that language difficulties may be a risk factor for communication and social interaction challenges and communication-related adaptive behavior in children with NF1. Though receptive language abilities were an area of particular difficulty for many children with NF1, they were not significantly related to parental ratings of social functioning and functional communication. Few significant relations were found between language and parent-reported attention problems, although some trends were noted. Hence attention difficulties in children with NF1 may contribute to, but do not appear to fully account for, language difficulties. In sum, there is an increased risk of language difficulties for young children with NF1, and lab-measured language difficulties appear to relate to everyday communication and social interaction functioning. Published by Elsevier Ltd.

Entities:  

Keywords:  Attention; Child-preschool; Communication; Genetic diseases; Language; Social skills

Mesh:

Year:  2014        PMID: 24995687     DOI: 10.1016/j.ridd.2014.06.016

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  7 in total

1.  Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.

Authors:  Deborah A Bilder; Amanda V Bakian; David A Stevenson; Paul S Carbone; Christopher Cunniff; Alyson B Goodman; William M McMahon; Nicole P Fisher; David Viskochil
Journal:  J Autism Dev Disord       Date:  2016-10

Review 2.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

3.  Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.

Authors:  Elizabeth I Pierpont; Rebekah L Hudock; Allison M Foy; Margaret Semrud-Clikeman; Mary Ella Pierpont; Susan A Berry; Ryan Shanley; Nathan Rubin; Katherine Sommer; Christopher L Moertel
Journal:  J Neurodev Disord       Date:  2018-06-18       Impact factor: 4.025

4.  Social behavior in RASopathies and idiopathic autism.

Authors:  Allison M H Foy; Rebekah L Hudock; Ryan Shanley; Elizabeth I Pierpont
Journal:  J Neurodev Disord       Date:  2022-01-12       Impact factor: 4.025

5.  Early Developmental Trajectories in Infants With Neurofibromatosis 1.

Authors:  Shruti Garg; Ming Wai Wan; Jannath Begum-Ali; Anna Kolesnik-Taylor; Jonathan Green; Mark H Johnson; Emily Jones
Journal:  Front Psychol       Date:  2022-07-22

6.  Early development of infants with neurofibromatosis type 1: a case series.

Authors:  Anna May Kolesnik; Emily Jane Harrison Jones; Shruti Garg; Jonathan Green; Tony Charman; Mark Henry Johnson
Journal:  Mol Autism       Date:  2017-11-23       Impact factor: 7.509

7.  Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies.

Authors:  Thomas Traunwieser; Daniela Kandels; Franz Pauls; Torsten Pietsch; Monika Warmuth-Metz; Brigitte Bison; Juergen Krauss; Rolf-Dieter Kortmann; Beate Timmermann; Ulrich-Wilhelm Thomale; Peggy Luettich; Anne Neumann-Holbeck; Tanja Tischler; Pablo Hernáiz Driever; Olaf Witt; Astrid K Gnekow
Journal:  Neurooncol Adv       Date:  2020-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.